RPTX
Price
$1.75
Change
+$0.01 (+0.57%)
Updated
Sep 17, 04:41 PM (EDT)
Capitalization
74.75M
49 days until earnings call
VIR
Price
$4.80
Change
-$0.06 (-1.23%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
675.13M
42 days until earnings call
Interact to see
Advertisement

RPTX vs VIR

Header iconRPTX vs VIR Comparison
Open Charts RPTX vs VIRBanner chart's image
Repare Therapeutics
Price$1.75
Change+$0.01 (+0.57%)
Volume$100
Capitalization74.75M
Vir Biotechnology
Price$4.80
Change-$0.06 (-1.23%)
Volume$4.94K
Capitalization675.13M
RPTX vs VIR Comparison Chart in %
Loading...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RPTX vs. VIR commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTX is a Hold and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (RPTX: $1.75 vs. VIR: $4.80)
Brand notoriety: RPTX and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RPTX: 23% vs. VIR: 63%
Market capitalization -- RPTX: $74.75M vs. VIR: $675.13M
RPTX [@Biotechnology] is valued at $74.75M. VIR’s [@Biotechnology] market capitalization is $675.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RPTX’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • RPTX’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, both RPTX and VIR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RPTX’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • RPTX’s TA Score: 4 bullish, 4 bearish.
  • VIR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RPTX is a better buy in the short-term than VIR.

Price Growth

RPTX (@Biotechnology) experienced а -0.57% price change this week, while VIR (@Biotechnology) price change was -6.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

RPTX is expected to report earnings on Nov 05, 2025.

VIR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($675M) has a higher market cap than RPTX($74.7M). RPTX YTD gains are higher at: 33.588 vs. VIR (-34.605). RPTX has higher annual earnings (EBITDA): -110.47M vs. VIR (-586.27M). VIR has more cash in the bank: 606M vs. RPTX (109M). RPTX has less debt than VIR: RPTX (649K) vs VIR (102M). VIR has higher revenues than RPTX: VIR (14.4M) vs RPTX (250K).
RPTXVIRRPTX / VIR
Capitalization74.7M675M11%
EBITDA-110.47M-586.27M19%
Gain YTD33.588-34.605-97%
P/E RatioN/AN/A-
Revenue250K14.4M2%
Total Cash109M606M18%
Total Debt649K102M1%
FUNDAMENTALS RATINGS
VIR: Fundamental Ratings
VIR
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
27
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RPTXVIR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 15 days ago
74%
Declines
ODDS (%)
Bearish Trend about 1 month ago
88%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTAWX14.31N/A
N/A
Fidelity Advisor Asset Manager 20% A
NEFJX20.77N/A
N/A
Natixis Vaughan Nelson Small Cap A
BRUSX35.32N/A
N/A
Bridgeway Ultra-Small Company
TBDQX22.03N/A
N/A
PGIM Jennison Diversified Growth R6
LFGSX43.19N/A
N/A
Lord Abbett Focused Growth R4

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+0.57%
INO - RPTX
51%
Loosely correlated
-4.39%
BCYC - RPTX
51%
Loosely correlated
N/A
CADL - RPTX
43%
Loosely correlated
-0.21%
ALNY - RPTX
38%
Loosely correlated
-2.06%
AXON - RPTX
37%
Loosely correlated
+0.15%
More